INIS
c-reactive protein
7%
comparative evaluations
7%
concentration
7%
coronaviruses
100%
correlations
14%
detection
7%
diseases
100%
ferritin
7%
fibrinogen
28%
heparin
100%
kidneys
100%
membranes
100%
monitoring
100%
patients
100%
range
21%
therapy
100%
thrombocytes
7%
thromboplastin
100%
Keyphrases
Activated Partial Thromboplastin Time (aPTT)
100%
Acute Phase Reactants
7%
Anti-Xa
21%
Antithrombin III (ATIII)
21%
Bland-Altman Analysis
7%
C-reactive Protein
7%
Chromogenic anti-Xa Assay
7%
Circuit Clotting
7%
Clot Detection
7%
Continuous Renal Replacement Therapy
100%
COVID-19
28%
Detection Method
7%
Ferritin
7%
Fibrinogen
28%
General Correlation
7%
Heparin
21%
Heparin Resistance
14%
Heparin Therapy
7%
Linear Regression
7%
Patient-specific
7%
Severe Cases
7%
Severe Coronavirus Disease 2019
100%
Therapeutic Range
21%
Thrombocytes
7%
Unfractionated Heparin
100%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
100%
Medicine and Dentistry
Acute Phase Protein
7%
Antithrombin III
21%
Blood Clotting Factor 8
28%
C Reactive Protein
7%
Continuous Renal Replacement Therapy
100%
COVID-19
100%
Extracorporeal Membrane Oxygenation
100%
Ferritin
7%
Fibrinogen
28%
Heparin
100%
Linear Regression Analysis
7%
Observational Study
100%
Partial Thromboplastin Time
100%
Platelet
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Phase Protein
7%
Antithrombin III
21%
Blood Clotting Factor 8
28%
C Reactive Protein
7%
Coronavirinae
100%
Diseases
100%
Ferritin
7%
Fibrinogen
28%
Heparin
100%
Observational Study
100%
Replacement Therapy
100%
Thromboplastin
100%
Biochemistry, Genetics and Molecular Biology
Acute Phase Protein
7%
Antithrombin
21%
C-Reactive Protein
7%
Coronavirinae
100%
Extracorporeal Oxygenation
100%
Factor VIII
28%
Ferritin
7%
Fibrinogen
28%
Heparin
100%
Observational Study
100%
Partial Thromboplastin Time
100%